Publicaciones en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (45)

2024

  1. Impact of treatment effect on MRD and PFS: an aggregate data analysis from randomized clinical trials in multiple myeloma

    Blood Advances

  2. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates

    Gut

2022

  1. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma

    New England Journal of Medicine, Vol. 386, Núm. 26, pp. 2471-2481

2021

  1. Microglia is associated with p-Tau aggregates in the olfactory bulb of patients with neurodegenerative diseases

    Neurological Sciences, Vol. 42, Núm. 4, pp. 1473-1482

2020

  1. Abnormal brain gamma oscillations in response to auditory stimulation in Dravet syndrome

    European Journal of Paediatric Neurology, Vol. 24, pp. 134-141

  2. RNU6-1 in circulating exosomes differentiates GBM from non-neoplastic brain lesions and PCNSL but not from brain metastases

    Neuro-Oncology Advances, Vol. 2, Núm. 1

2019

  1. Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature

    Blood Cancer Journal, Vol. 9, Núm. 4

2018

  1. An Inducible Promoter Responsive to Different Porphyrinogenic Stimuli Improves Gene Therapy Vectors for Acute Intermittent Porphyria

    Human Gene Therapy, Vol. 29, Núm. 4, pp. 480-491

  2. Systemic messenger RNA as an etiological treatment for acute intermittent porphyria

    Nature Medicine, Vol. 24, Núm. 12, pp. 1899-1909

  3. Theta-phase closed-loop stimulation induces motor paradoxical responses in the rat model of Parkinson disease

    Brain Stimulation, Vol. 11, Núm. 1, pp. 231-238

2017

  1. A typical antipsychotics normalize low-gamma evoked oscillations in patients with schizophrenia

    Psychiatry Research, Vol. 247, pp. 214-221

  2. Effect of dexmedetomidine and propofol on basal ganglia activity in Parkinson disease a controlled clinical trial

    Anesthesiology, Vol. 126, Núm. 6, pp. 1033-1042

2016

  1. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: A new approach for active contact localization

    Journal of Neurosurgery, Vol. 125, Núm. 5, pp. 1068-1079

2015

  1. Coupling in the cortico-basal ganglia circuit is aberrant in the ketamine model of schizophrenia

    European Neuropsychopharmacology, Vol. 25, Núm. 8, pp. 1375-1387

  2. Factors Associated with Tremor Changes during Sedation with Dexmedetomidine in Parkinson's Disease Surgery

    Stereotactic and Functional Neurosurgery, Vol. 93, Núm. 6, pp. 393-399

  3. Long-term continuous positive airway pressure therapy improves cardiac autonomic tone during sleep in patients with obstructive sleep apnea

    Clinical Autonomic Research, Vol. 25, Núm. 4, pp. 225-232

2014

  1. Basal cardiac autonomic tone is normal in patients with periodic leg movements during sleep

    Journal of Neural Transmission, Vol. 121, Núm. 4, pp. 385-390

  2. Cardiac autonomic impairment during sleep as a marker of human prion diseases: A preliminary report

    Clinical Neurophysiology

  3. Characterizing the phenotypes of obstructive sleep apnea: Clinical, sleep, and autonomic features of obstructive sleep apnea with and without hypoxia

    Clinical Neurophysiology, Vol. 125, Núm. 9, pp. 1783-1791

  4. High beta activity in the subthalamic nucleus and freezing of gait in Parkinson's disease

    Neurobiology of Disease, Vol. 64, pp. 60-65